EGFR and neoplasm: Moreover, TNF-α is one of the angiogenic factors associated with tumour-induced neovascularisation (Wu et al, 2000) and gefitinib has been shown to inhibit EGFR-mediated migration and tube-like formation of human microvascular endothelial cells (Hirata et al, 2002).